Ghent University Academic Bibliography

The more, the merrier? Establishing a dose-response relationship for the effects of cognitive control training on depressive symptomatology

Yannick Vander Zwalmen (UGent) , David Demeester (UGent) , Kristof Hoorelbeke (UGent) , Nick Verhaeghe (UGent) , Chris Baeken (UGent) and Ernst Koster (UGent)

(2025) JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY. 93(3). p.161-175

Add to list

Journal Article
A1
open access

Service providers’ perceptions of substitute addictions in the Western Cape, South Africa

Deborah Louise Sinclair (UGent) , Steve Sussman, Lize Vantomme, Maria Florence, Shazly Savahl and Wouter Vanderplasschen (UGent)

(2024) JOURNAL OF DRUG ISSUES. 54(2). p.268-290

Add to list

Journal Article
A1
open access

Computerized cognitive control training to reduce rumination in major depression : a randomized controlled trial

Ulrike Zetsche, Pauline Neumann, Paul-Christian Bürkner, Babette Renneberg, Ernst Koster (UGent) and Kristof Hoorelbeke (UGent)

(2024) BEHAVIOUR RESEARCH AND THERAPY. 177.

Add to list

Journal Article
A1
open access

Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

Wei Z. Yeh, Anneke Van Der Walt, Olga G. Skibina, Tomas Kalincik, Raed Alroughani, Allan G. Kermode, Marzena J. Fabis-Pedrini, William M. Carroll, Jeannette Lechner-Scott, Cavit Boz, et al.

(2024) NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 11(6).

Add to list

Journal Article
A1
open access

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, et al.

(2024) THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 17.

Add to list

Journal Article
A2
open access

High-frequency cognitive control training for depression : a single case study

Yannick Vander Zwalmen (UGent) , Kristof Hoorelbeke (UGent) , David Demeester (UGent) and Ernst Koster

(2024) JMIR FORMATIVE RESEARCH. 8.

Add to list

Journal Article
A1
open access

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma : ELARA trial update

Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chavez, Emmanuel Bachy, et al.

(2024) BLOOD. 143(17). p.1713-1725

Add to list

Journal Article
A1
open access

Post-discharge outcomes of elderly patients hospitalized for inflammatory bowel disease flare complicated by Clostridioides difficile infection

Idan Goren, Ortal Fallek Boldes, Tomer Boldes, Oleg Knyazev, Anna Kagramanova, Jimmy K Limdi, Eleanor Liu, Karishma Sethi-Arora, Tom Holvoet, Piotr Eder, et al.

(2024) JOURNAL OF CROHNS & COLITIS.

Add to list

Journal Article
A1
open access

Atypical psychiatric presentation of relapsing anti-N-methyl-D-aspartate receptor encephalitis in childhood

Joke Depreitere, Jan De Meulenaere (UGent) and Helene Verhelst (UGent)

(2023) CLINICAL CHILD PSYCHOLOGY AND PSYCHIATRY. 28(4). p.1333-1340

Add to list

Journal Article
A1
open access

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis : results from MSBase registry

T Spelman, S Ozakbas, R Alroughani, M Terzi, S Hodgkinson, Guy Laureys (UGent) , T Kalincik, A Van Der Walt, B Yamout, J Lechner-Scott, et al.

(2023) MULTIPLE SCLEROSIS JOURNAL. 29(2). p.221-235

Academic Bibliography

The more, the merrier? Establishing a dose-response relationship for the effects of cognitive control training on depressive symptomatology

Service providers’ perceptions of substitute addictions in the Western Cape, South Africa

Computerized cognitive control training to reduce rumination in major depression : a randomized controlled trial

Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

High-frequency cognitive control training for depression : a single case study

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma : ELARA trial update

Post-discharge outcomes of elderly patients hospitalized for inflammatory bowel disease flare complicated by Clostridioides difficile infection

Atypical psychiatric presentation of relapsing anti-N-methyl-D-aspartate receptor encephalitis in childhood

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis : results from MSBase registry

Contents

Support

Contact